跳至主要内容
临床试验/EUCTR2006-001265-41-GB
EUCTR2006-001265-41-GB进行中(未招募)1 期

A comparison of Sirolimus versus Tacrolimus as a delayed treatment of recipients of non heart beating donor kidneys after anti-IL2 monoclonal antibody - Sirolimus vs Tacrolimus for NHBD Kidney Recipients after IL-2 mAb

ewcastle upon Tyne Hospitals NHS Trust0 个研究点目标入组 60 人开始时间: 2006年4月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Recipients of kidneys from non heart beating donors
  • Written informed consent obtained from the patient after receiving a comprehensive explanation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Pregnant women
  • Recipients of multiple transplants (e.g. Both kidneys from one donor transplanted into one recipient or a simultaneous kidney and liver or kidney and pancreas transplant)

研究者

发起方
ewcastle upon Tyne Hospitals NHS Trust

相似试验

A comparison of Sirolimus versus Tacrolimus as a... | 临床试验